Stockholm Medical Cannabis Conference

The Role of Cannabinoids in SARS-CoV-2 Infection and COVID-19 Management

This article delves into the rapidly growing realm of cannabinoids as potential therapeutic agents in managing COVID-19, engendered by SARS-CoV-2. By navigating through the antiviral and immunomodulatory properties of cannabinoids, the article seeks to provide a nuanced understanding of their potential impact on disease management, while elucidating the pivotal clinical and molecular mechanisms at play. The need for robust clinical trials and further research to corroborate these early insights is emphasized, heralding a call to action for the global scientific community.

This comprehensive article delves into the multifaceted roles of the Endocannabinoid System (ECS) in maintaining physiological homeostasis across multiple organ systems. From its influence on the nervous system and pain regulation to its complex interplay with metabolic and emotional regulation, the article argues for a broader integration of ECS understanding into medical education and personalized medicine.

Exploring Autistic Spectrum Disorder through the lens of ECS dysfunction

Explore the compelling links between the Endocannabinoid System (ECS) and Autism Spectrum Disorders (ASD). This in-depth review delves into genetic and chemically-induced in vivo models, ECS biomarkers in ASD, and the latest clinical research on ECS-targeted interventions. Understand the ECS’s role as a potential therapeutic target and its broader implications for ASD pathology and treatment.

Decoding the Symphony: Genetic Variations in the ECS and Their Impact on Health

This comprehensive review delves into the genetic intricacies of the Endocannabinoid System (ECS) or Master Homeostatic Regulatory System (MHRS), illuminating its pivotal role in physiological homeostasis and its susceptibility to genetic mutations. By exploring the impact of these variations on behavior and disease, the article aims to serve as a foundation for future research and therapeutic developments in this burgeoning field.

Improving cannabinoid posology through nanotechnology

This article explores the role of nanotechnology in improving the delivery and efficacy of cannabinoids. By focusing on nanoencapsulation techniques such as liposomes and polymeric nanoparticles, we delve into how these methods can enhance bioavailability, stability, and therapeutic efficacy of cannabinoids, thereby offering significant advancements in molecular pharmacology.

The Gut-Brain Axis and Its Influence Over Endocannabinoid Tone

Explore the fascinating connection between the gut, brain, and bliss in this insightful article. Discover how the gut microbiota and the endocannabinoid system influence brain function, mood, and overall health. Gain insights into the potential therapeutic approaches and the exciting possibilities for personalized medicine in this emerging field of research.

Beyond the High: Unraveling Non-GPCR Targets in the eCBome

Delve into the lesser-known facets of the endocannabinoid system (eCBome), focusing on non-GPCR targets like FAAH, MAGL, DAGL, NAPE-PLD, TRP channels, and PPARs. Discover their critical roles in human physiology and their potential for therapeutic intervention in neuropsychiatric, metabolic, and neurological disorders.